US Stock MarketDetailed Quotes

ZVSA ZyVersa Therapeutics

Watchlist
  • 4.4700
  • +0.1799+4.19%
Trading May 24 11:01 ET
3.73MMarket Cap-34P/E (TTM)

ZyVersa Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ZyVersa Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-4.53

+96.67%
Analyst Rating

Buy

May 24, 2024

ZyVersa Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--

ZyVersa Therapeutics Earnings Reports

  • 10-Q: Quarterly report

    May 15 08:35 ET

  • 10-K/A: Annual report (Amendment)

    May 15 08:30 ET

  • ZyVersa Therapeutics | 10-K: Annual report

    Mar 25 08:03 ET

  • ZyVersa Therapeutics: Q3 2023 Earnings Report

    Nov 14, 2023 16:34 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: May 24, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg